Press "Enter" to skip to content

HNL Lab Medicine CEO to retire; to be succeeded by LVHN vice chair

Matthew Sorrentino to retire as HNL Lab Medicine president and CEO. Martin Till will be his successor.
Source: Morningcall

Call Now Button
%d bloggers like this: